Asthma (Respiratory) - Drugs In Development, 2021

Publisher Name :
Date: 30-Aug-2021
No. of pages: 931
Inquire Before Buying

Asthma (Respiratory) - Drugs In Development, 2021

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Drugs In Development, 2021, provides an overview of the Asthma (Respiratory) pipeline landscape.Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include family history, overweight, smoking, exposure to exhaust fumes or other types of pollution and exposure to occupational triggers, such as chemicals used in farming, hairdressing and manufacturing. Treatment includes inhaled corticosteroids, leukotriene modifiers, antihistamines and decongestants.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Asthma - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Asthma (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 1, 16, 40, 48, 10, 136, 38 and 9 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 33 and 10 molecules, respectively.

Asthma (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Asthma (Respiratory).

- The pipeline guide reviews pipeline therapeutics for Asthma (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Asthma (Respiratory) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Asthma (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Asthma (Respiratory)

Reasons to Buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Asthma (Respiratory).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Asthma (Respiratory) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Asthma (Respiratory) - Drugs In Development, 2021

Table of Contents
Introduction
Asthma - Overview
Asthma - Therapeutics Development
Asthma - Therapeutics Assessment
Asthma - Companies Involved in Therapeutics Development
Asthma - Drug Profiles
Asthma - Dormant Projects
Asthma - Discontinued Products
Asthma - Product Development Milestonesh
Appendix

List of Tables
Number of Products under Development for Asthma, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Asthma - Pipeline by 2A Pharma AB, 2021
Asthma - Pipeline by 3SBio Inc, 2021
Asthma - Pipeline by 4D Pharma Plc, 2021
Asthma - Pipeline by AazeinTx Inc, 2021
Asthma - Pipeline by AB Science SA, 2021
Asthma - Pipeline by AbbVie Inc, 2021
Asthma - Pipeline by Abeome Corp, 2021
Asthma - Pipeline by Actinobac Biomed Inc, 2021
Asthma - Pipeline by Adare Pharma Solutions, 2021
Asthma - Pipeline by Advagene Biopharma Co Ltd, 2021
Asthma - Pipeline by Aeon Respire Inc, 2021
Asthma - Pipeline by Airbase Breathing Co LLC, 2021
Asthma - Pipeline by Akeso Inc, 2021
Asthma - Pipeline by Aldeyra Therapeutics Inc, 2021
Asthma - Pipeline by Algomedix Inc, 2021
Asthma - Pipeline by ALK-Abello AS, 2021
Asthma - Pipeline by AllerGen NCE Inc, 2021
Asthma - Pipeline by Allergy Therapeutics Plc, 2021
Asthma - Pipeline by Amgen Inc, 2021
Asthma - Pipeline by Amphastar Pharmaceuticals Inc, 2021
Asthma - Pipeline by AnGes Inc, 2021
Asthma - Pipeline by Antisense Therapeutics Ltd, 2021
Asthma - Pipeline by Apollo Therapeutics LLC, 2021
Asthma - Pipeline by Aquilon Pharmaceuticals SA, 2021
Asthma - Pipeline by Argenx SE, 2021
Asthma - Pipeline by Artax Biopharma Inc, 2021
Asthma - Pipeline by Artizan Biosciences Inc, 2021
Asthma - Pipeline by ASIT Biotech SA, 2021
Asthma - Pipeline by Aslan Pharmaceuticals Ltd, 2021
Asthma - Pipeline by AstraZeneca Plc, 2021
Asthma - Pipeline by Athos Therapeutics Inc, 2021
Asthma - Pipeline by Atrapos Therapeutics LLC, 2021
Asthma - Pipeline by AusBio Ltd, 2021
Asthma - Pipeline by Avidin Biotechnology Ltd, 2021
Asthma - Pipeline by Bai Shuo Beijing Pharmaceutical Technology Co Ltd, 2021
Asthma - Pipeline by Bilix Co Ltd, 2021
Asthma - Pipeline by BioArdis LLC, 2021
Asthma - Pipeline by Biocon Ltd, 2021
Asthma - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, 2021
Asthma - Pipeline by BiOraliX BV, 2021
Asthma - Pipeline by BiosanaPharma BV, 2021
Asthma - Pipeline by Biosion Inc, 2021
Asthma - Pipeline by Biotoxtech Co Ltd, 2021
Asthma - Pipeline by Boehringer Ingelheim International GmbH, 2021
Asthma - Pipeline by Celltrion Inc, 2021
Asthma - Pipeline by Celon Pharma SA, 2021
Asthma - Pipeline by Centrymed Pharmaceutical Inc, 2021
Asthma - Pipeline by Chia Tai Tianqing Pharmaceutical Group Co Ltd, 2021
Asthma - Pipeline by Chiesi Farmaceutici SpA, 2021
Asthma - Pipeline by Chronic Airway Therapeutics Ltd, 2021
Asthma - Pipeline by Crossject SA, 2021
Asthma - Pipeline by CrystalGenomics Inc, 2021
Asthma - Pipeline by CSL Ltd, 2021
Asthma - Pipeline by CSPC Pharmaceutical Group Ltd, 2021
Asthma - Pipeline by Cumberland Pharmaceuticals Inc, 2021
Asthma - Pipeline by Curovir AB, 2021
Asthma - Pipeline by Cynata Therapeutics Ltd, 2021
Asthma - Pipeline by Cytokinetics Inc, 2021
Asthma - Pipeline by Daewoong Pharmaceutical Co Ltd, 2021
Asthma - Pipeline by Daiichi Sankyo Co Ltd, 2021
Asthma - Pipeline by Defensin Therapeutics ApS, 2021
Asthma - Pipeline by Dnarx LLC, 2021
Asthma - Pipeline by EffectorBio Inc, 2021
Asthma - Pipeline by EmphyCorp Inc, 2021
Asthma - Pipeline by Energenesis Biomedical Co Ltd, 2021
Asthma - Pipeline by Enzychem Lifesciences Corp, 2021
Asthma - Pipeline by Epsilon Molecular Engineering Inc, 2021
Asthma - Pipeline by ethris GmbH, 2021
Asthma - Pipeline by EURRUS Biotech GmbH, 2021
Asthma - Pipeline by Evelo Biosciences Inc, 2021
Asthma - Pipeline by Evergreen Therapeutics Inc, 2021
Asthma - Pipeline by Exotect LLC, 2021
Asthma - Pipeline by Fibrotherapeutics Inc, 2021
Asthma - Pipeline by Foresee Pharmaceuticals Co Ltd, 2021
Asthma - Pipeline by Galapagos NV, 2021
Asthma - Pipeline by Genentech USA Inc, 2021
Asthma - Pipeline by Generium, 2021
Asthma - Pipeline by GeneScience Pharmaceuticals Co Ltd, 2021
Asthma - Pipeline by Genrix (Shanghai) Biopharmaceutical Co Ltd, 2021
Asthma - Pipeline by GI Innovation Co Ltd, 2021
Asthma - Pipeline by GlaxoSmithKline Plc, 2021
Asthma - Pipeline by Glenmark Pharmaceuticals Ltd, 2021
Asthma - Pipeline by GliaCure Inc, 2021
Asthma - Pipeline by GlycoMira Therapeutics Inc, 2021
Asthma - Pipeline by Gossamer Bio Inc, 2021
Asthma - Pipeline by Gurus BioPharm, 2021
Asthma - Pipeline by Harbour BioMed (Guangzhou) Co Ltd, 2021
Asthma - Pipeline by HEC Pharma Co Ltd, 2021
Asthma - Pipeline by Re-Pharm Ltd, 2021
Asthma - Pipeline by Regeneron Pharmaceuticals Inc, 2021
Asthma - Pipeline by Respiratorius AB, 2021
Asthma - Pipeline by Revalesio Corp, 2021
Asthma - Pipeline by Revolo Biotherapeutics Ltd, 2021
Asthma - Pipeline by Ribomic Inc, 2021
Asthma - Pipeline by S-TARget therapeutics GmbH, 2021
Asthma - Pipeline by Sama Pharm Co Ltd, 2021
Asthma - Pipeline by Sanofi, 2021
Asthma - Pipeline by Santhera Pharmaceuticals Holding AG, 2021
Asthma - Pipeline by Seelos Therapeutics, Inc., 2021
Asthma - Pipeline by Shandong Boan Biotechnology Co Ltd, 2021
Asthma - Pipeline by Shanghai KE Pharmaceutical Co Ltd, 2021
Asthma - Pipeline by Shanghai Kexin Biotech Co Ltd, 2021
Asthma - Pipeline by Shanghai Maiji Biotechnology Co Ltd, 2021
Asthma - Pipeline by Shanghai Novamab Biopharmaceuticals Co Ltd, 2021
Asthma - Pipeline by Shenzhen Forward Pharmaceutical Co Ltd, 2021
Asthma - Pipeline by Shouyao Holding Co Ltd, 2021
Asthma - Pipeline by Sichuan Yuanda Shuyang Pharmaceutical Co Ltd, 2021
Asthma - Pipeline by Siolta Therapeutics Inc, 2021
Asthma - Pipeline by SolAeroMed Inc, 2021
Asthma - Pipeline by sterna biologicals Gmbh & Co KG, 2021
Asthma - Pipeline by Suzhou Connect Biopharmaceuticals Ltd, 2021
Asthma - Pipeline by Synermore Biologics Co Ltd, 2021
Asthma - Pipeline by Taiho Pharmaceutical Co Ltd, 2021
Asthma - Pipeline by TaiwanJ Pharmaceuticals Co Ltd, 2021
Asthma - Pipeline by TAK-Circulator Corp, 2021
Asthma - Pipeline by Tarus Therapeutics Inc, 2021
Asthma - Pipeline by TCF GmbH, 2021
Asthma - Pipeline by Tetherex Pharmaceuticals Corp, 2021
Asthma - Pipeline by Tetragenetics Inc, 2021
Asthma - Pipeline by Teva Pharmaceutical Industries Ltd, 2021
Asthma - Pipeline by TFF Pharmaceuticals Inc, 2021
Asthma - Pipeline by The Geneva Biotech Center SA, 2021
Asthma - Pipeline by The United Laboratories International Holdings Ltd, 2021
Asthma - Pipeline by Torrent Pharmaceuticals Ltd, 2021
Asthma - Pipeline by Translational Biosciences, 2021
Asthma - Pipeline by Trio Medicines Ltd, 2021
Asthma - Pipeline by Tunitas Therapeutics Inc, 2021
Asthma - Pipeline by United Biomedical Inc, 2021
Asthma - Pipeline by Vactech Oy, 2021
Asthma - Pipeline by Vanworld Pharmaceutical (Rugao) Company Ltd, 2021
Asthma - Pipeline by Vascular BioSciences, 2021
Asthma - Pipeline by Vasomune Inc, 2021
Asthma - Pipeline by Vectura Group Plc, 2021
Asthma - Pipeline by Verona Pharma Plc, 2021
Asthma - Pipeline by VGSK Technologies Inc, 2021
Asthma - Pipeline by Vicenna Pharmaceuticals Inc, 2021
Asthma - Pipeline by Virtici LLC, 2021
Asthma - Pipeline by Yuhan Corp, 2021
Asthma - Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, 2021
Asthma - Pipeline by Zhengda Tianqing Pharmaceutical Group Co Ltd, 2021
Asthma - Pipeline by Zhuhai Trinomab Biotechnology Co Ltd, 2021
Asthma - Dormant Projects, 2021
Asthma - Discontinued Products, 2021

List of Figures
Number of Products under Development for Asthma, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021
  • Global and Japan Bovine Respiratory Disease Treatment Market Size, Status and Forecast 2021-2027
    Published: 05-Oct-2021        Price: US 3900 Onwards        Pages: 97
    Global Bovine Respiratory Disease Treatment Scope and Market Size Bovine Respiratory Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bovine Respiratory Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the p......
  • United States Ambroxol Market Report & Forecast 2021-2027
    Published: 30-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Ambroxol Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) United States Ambroxol Market Segment Percentages, By Type, 2020 (%) - Normal type - Long-acting type United States Ambroxol Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) United States Ambroxol Market Segment Percentages, By Application, 2020 (%) - Acute Respiratory Diseases - Chronic Respiratory Diseases Competitor Anal......
  • Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021
    Published: 21-Sep-2021        Price: US 2500 Onwards        Pages: 250
    Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021 Summary GlobalData's clinical trial report, "Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021" provides an overview of Obstructive Sleep Apnea Clinical trials scenario. This report provides top line data relating to the clinical trials on Obstructive Sleep Apnea . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The rep......
  • Global and China Carbocisteine Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 139
    Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. In this report, we study the Carbocisteine API. Global Carbocisteine key players include Moehs......
  • United States Carbocisteine Market Report & Forecast 2021-2027
    Published: 09-Sep-2021        Price: US 3400 Onwards        Pages: 91
    United States Carbocisteine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Carbocisteine Market Segment Percentages, By Type, 2020 (%) - 0.985 - Above 98.50% United States Carbocisteine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Carbocisteine Market Segment Percentages, By Application, 2020 (%) - Oral Solution - Tablet & Capsule - Others Competitor Analysis......
  • Cystic Fibrosis (CF) - Epidemiology Forecast to 2030
    Published: 31-Aug-2021        Price: US 3995 Onwards        Pages: 41
    Cystic Fibrosis (CF) - Epidemiology Forecast to 2030 Summary Cystic fibrosis (CF) is a progressive, inherited disorder that primarily affects the respiratory and digestive systems. In people with CF, mucus, sweat, and other fluids produced in these systems are sticky and thick, and may obstruct the passageways in the lungs and pancreas (Mayo Clinic, 2021). Mucus build-up and airway blockages in the lungs cause symptoms such as persistent cough, wheezing, inflamed nasal ......
  • Bronchiectasis (Respiratory) - Drugs In Development, 2021
    Published: 30-Aug-2021        Price: US 2000 Onwards        Pages: 123
    Bronchiectasis (Respiratory) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2021, provides an overview of the Bronchiectasis (Respiratory) pipeline landscape.Bronchiectasis is a chronic condition where the walls of the bronchial tubes are permanently damaged. These damage allow bacteria and mucus to build up in lungs. Bronchiectasis is divided into two catego......
  • Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021
    Published: 30-Aug-2021        Price: US 2500 Onwards        Pages: 675
    Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease - Drugs In Development, 2021, provides an overview of the Chronic Obstructive Pulmonary Disease (Respiratory) pipeline landscape.Chronic obstructive pulmonary disease (COPD) is a group of lung diseases. It is characterized by inability to completely breath......
  • Idiopathic Pulmonary Fibrosis (Respiratory) - Drugs In Development, 2021
    Published: 30-Aug-2021        Price: US 2500 Onwards        Pages: 697
    Idiopathic Pulmonary Fibrosis (Respiratory) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis - Drugs In Development, 2021, provides an overview of the Idiopathic Pulmonary Fibrosis (Respiratory) pipeline landscape.Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease characterized by inflammation and scarring of lung tissue and loss of lung function. Sy......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs